As Arizonans vote with early ballots or prepare to go to the polls in November, 50 Arizona physicians explained why it is important to vote “no” on Proposition 303 and Joan Koerber-Walker explains her personal concerns with this piece of public policy in a debate on Arizona Horizon. Continue reading
Category Archives: Advocacy and Regulations
Pathway Progress – Biosimilars Are Coming Soon
In 2013, “biosimilars” were a hot topic at the Arizona Legislature. In the end, the bill to define the classes of biosimilars in Arizona statute along with the the process for substitution did not move forward to the floor as key stateholders and legislators continued to research and discuss the issue.
It is expected that the first biosimilars will be approved by the FDA in 2015 and that the states that have yet to up date their pharmacy acts (including Arizona) will be opening up these discussions again.Continue reading
Washington Update for October 2014
This Washington Update for CSBA is provided to AZBio Members as an update on issues that affect our industry at the nation’s capitol.Continue reading
Understanding Prop 303 – The Right to Try
This November, Arizona voters will have an opportunity to decide if Proposition 303 called “The Right to Try” should become law in Arizona. It is important to understand what this proposed law does and does not do.Continue reading
Before the Recess: Washington Update for CSBA
Legislators wrapped up their summer work in July before leaving town for the August recess, but not without some last minute drama over the Highway Trust Fund (HTF) and the border supplemental bill. Ultimately, lawmakers passed a funding extension for the Highway Trust Fund (HTF), staving off a financial crisis. Congress also moved forward on several tax items and continued to hold oversight hearings on the Affordable Care Act (ACA) implementation.Continue reading
AdvaMed and MEDEC Approve Guidances on Ethical Relationships with Third-Party Distributors
WASHINGTON, D.C. – The Advanced Medical Technology Association (AdvaMed) and the Canadian medical technology association MEDEC announce that MEDEC recently approved a number of guidances and tools designed to promote ethical interactions between medical device and diagnostics companies and third-party distributors.
Independence, Independents, and the Importance of Your Vote
Each July 4th we celebrate our independence as a nation and as a free people. The freedom and the opportunity to elect our leaders and representatives is as important today as it was in 1776.
Penny Wise and Pound Foolish – Castellani answers critics on drug prices with facts.
Castellani Statement on Prescription Drug Costs
Washington, D.C. (May 29, 2014) – The Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John Castellani today released the following statement on the cost and value of medicines:Continue reading
21st Century Cures Continues Seeking Feedback
Second White Paper Reviews Proposals Made in the President’s Council of Advisors on Science and Technology 2012 Report on Propelling Innovation – Health Subcommittee Schedules Hearing on PCAST for May 20 Continue reading